SCHEMBL3115322

SCHEMBL3115322

O=C(O)CCCN(CC1CCCCC1)C(=O)C(=O)c1c[nH]c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 4/20 0.52
MC5R P33032 4/20 0.52
MC3R P41968 3/20 0.52
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
GABRA1 P14867 6/20 0.48
GABRG2 P18507 6/20 0.48
GABRB3 P28472 6/20 0.48
GABRA3 P34903 6/20 0.48
GABRA2 P47869 6/20 0.48
GABRB2 P47870 6/20 0.48
ADAM17 P78536 1/20 0.47
HTR4 Q13639 2/20 0.47
POLB P06746 1/20 0.46
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA4 P48169 1/20 0.44
GABRE P78334 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3119512 0.95 RAB9A (0.53) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL7937764 0.80 RAB9A (0.43) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL3119504 0.80 RAB9A (0.43) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL3262320 0.76 RAB9A (0.47) RAB9ANPC1GABRA1GABRG2GABRB3
SCHEMBL3942077 0.75 RAB9A (0.55) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL3129331 0.75 MEN1 (0.42) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL3942488 0.75 RAB9A (0.49) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL3118297 0.75 MC4R (0.48) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL3118314 0.75 MC4R (0.48) MC4RMC5RMC3RRAB9ANPC1
SCHEMBL3120950 0.74 ALDH1A1 (0.40) RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed